MedTrace Logo

Evaluation of Novel Noise Reduction Principles in Hearing Instruments

NCT05582408 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2022-11-17

No results posted yet for this study

Summary

In the study, the speech intelligibility in noise (Outcome) between a novel noise reduction algorithm (Intervention) versus the standard noise reduction (Comparator) will be tested in adults with a N3-N4 hearing loss (Population) using streamed signals via hearing aids.

Conditions

Interventions

DEVICE

Measures of Standard Noise Reduction NR1

Each participant will be fitted with the Standard Noise Reduction (NR1)

DEVICE

Measures of Noise Reduction Principle NR2

Each participant will be fitted with the novel Noise Reduction principle NR2 on the same hearing aid

DEVICE

Measure of Noise Reduction Principle NR3

Each participant will be fitted with the novel Noise Reduction principle NR3 on the same hearing aid

Sponsors & Collaborators

  • Sonova AG

    lead INDUSTRY

Principal Investigators

  • Marlene Zippel · Sonova AG

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-12
Primary Completion
2022-10-25
Completion
2022-11-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05582408 on ClinicalTrials.gov